Association study of ARL15 and CDH13 with T2DM in a Han Chinese population

International Journal of Medical Sciences

Volumn 11, Issue 5, 2014, Pages 522-527

  Li, Yiping ^a,b   Yang, Ying ^b   Yao, Yueting ^c   Li, Xianli ^b   Shi, Li ^c   Zhang, Ying ^b   Xiong, Yuxin ^b   Yan, Man ^b   Yao, Yufeng ^c   Xiao, Chunjie ^a  

^a YUNNAN UNIVERSITY   (China)

^b Second People's Hospital of Yunnan Province   (China)

^c INSTITUTE OF MEDICAL BIOLOGY   (China)

Author keywords

ARL15; CDH13; Chinese population; SNP; T2DM

Indexed keywords

ADULT; ALLELE; ARL15 GENE; ARTICLE; CDH13 GENE; CHINESE; CLINICAL EVALUATION; CONTROLLED STUDY; FEMALE; GENE; GENE FREQUENCY; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENOTYPE; HUMAN; INHERITANCE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOGENESIS; POPULATION RESEARCH; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; CHINA; GENETIC PREDISPOSITION; GENETICS; PATHOLOGY;

ADENOSINE DIPHOSPHATE RIBOSYLATION FACTOR; ARL15 PROTEIN, HUMAN; CADHERIN; H-CADHERIN;

ADP-RIBOSYLATION FACTORS; ALLELES; CADHERINS; CHINA; DIABETES MELLITUS, TYPE 2; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84898482593     PISSN: 14491907     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijms.8206     Document Type: Article

References (41)

1. Yang W, Lu J, Weng J, et al. Prevalence of diabetes among men and women in China. N Engl J Med. 2010; 362: 1090-1101.
2. Weyer C, Funahashi T, Tanaka S, et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab. 2001; 86: 1930-1935.
3. Tschritter O, Fritsche A, Thamer C, et al. Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism. Diabetes. 2003; 52: 239-243.
4. Abbasi F, Chu JW, Lamendola C, et al. Discrimination between obesity and insulin resistance in the relationship with adiponectin. Diabetes. 2004; 53: 585-590.
5. Retnakaran R, Hanley AJ, Raif N, et al. Adiponectin and beta cell dysfunction in gestational diabetes: pathophysiological implications. Diabetologia. 2005; 48: 993-1001.
6. Li S, Shin HJ, Ding EL, et al. Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA. 2009; 302: 179-188.
7. Arita Y, Kihara S, Ouchi N, et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun. 1999; 257: 79-83.
8. Yang WS, Lee WJ, Funahashi T, et al. Plasma adiponectin levels in overweight and obese Asians. Obes Res. 2002; 10: 1104-1110.
9. Matsubara M, Maruoka S, Katayose S. Decreased plasma adiponectin concentrations in women with dyslipidemia. J Clin Endocrinol Metab. 2002; 87: 2764-2769.
10. Hotta K, Funahashi T, Arita Y, et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol. 2000; 20: 1595-1599.
11. Kumada M, Kihara S, Sumitsuji S, et al. Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol. 2003; 23: 85-89.
12. Schutte AE, Huisman HW, Schutte R, et al. Differences and similarities regarding adiponectin investigated in African and Caucasian women. Eur J Endocrinol. 2007; 157: 181-188.
13. Mente A, Razak F, Blankenberg S, et al. Ethnic variation in adiponectin and leptin levels and their association with adiposity and insulin resistance. Diabetes Care. 2010; 33: 1629-1634.
14. Gillingham AK, Munro S. The small G proteins of the Arf family and their regulators. Annu Rev Cell Dev Biol. 2007; 23: 579-611.
15. Richards JB, Waterworth D, O'Rahilly S, et al. A genome-wide association study reveals variants in ARL15 that influence adiponectin levels. PLoS Genet. 2009; 5: e1000768.
16. Chung CM, Lin TH, Chen JW, et al. A genome-wide association study reveals a quantitative trait locus of adiponectin on CDH13 that predicts cardiometabolic outcomes. Diabetes. 2011; 60: 2417-2423.
17. Morisaki H, Yamanaka I, Iwai N, et al. CDH13 gene coding T-cadherin influences variations in plasma adiponectin levels in the Japanese population. Hum Mutat. 2012; 33: 402-410.
18. Sole X, Guino E, Valls J, et al. SNPStats: a web tool for the analysis of association studies. Bioinformatics. 2006; 22: 1928-1929.
19. Ling H, Waterworth DM, Stirnadel HA, et al. Genome-wide linkage and association analyses to identify genes influencing adiponectin levels: the GEMS Study. Obesity (Silver Spring). 2009; 17: 737-744.
20. Heid IM, Henneman P, Hicks A, et al. Clear detection of ADIPOQ locus as the major gene for plasma adiponectin: results of genome-wide association analyses including 4659 European individuals. Atherosclerosis. 2010; 208: 412-420.
21. Jee SH, Sull JW, Lee JE, et al. Adiponectin concentrations: a genome-wide association study. Am J Hum Genet. 2010; 87: 545-552.
22. Wu Y, Li Y, Lange EM, et al. Genome-wide association study for adiponectin levels in Filipino women identifies CDH13 and a novel uncommon haplotype at KNG1-ADIPOQ. Hum Mol Genet. 2010; 19: 4955-4964.
23. Dastani Z, Hivert MF, Timpson N, et al. Novel loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits: a multi-ethnic meta-analysis of 45,891 individuals. PLoS Genet. 2012; 8: e1002607.
24. Gao H, Kim YM, Chen P, et al. Genetic variation in CDH13 is associated with lower plasma adiponectin levels, but greater adiponectin sensitivity in East Asian populations. Diabetes. 2013.
25. Ishiki M, Klip A. Minireview: recent developments in the regulation of glucose transporter-4 traffic: new signals, locations, and partners. Endocrinology. 2005; 146: 5071-5078.
26. Fuss B, Becker T, Zinke I, et al. The cytohesin Steppke is essential for insulin signalling in Drosophila. Nature. 2006; 444: 945-948.
27. Hofmann I, Thompson A, Sanderson CM, et al. The Arl4 family of small G proteins can recruit the cytohesin Arf6 exchange factors to the plasma membrane. Curr Biol. 2007; 17: 711-716.
28. Hou JC, Pessin JE. Ins (endocytosis) and outs (exocytosis) of GLUT4 trafficking. Curr Opin Cell Biol. 2007; 19: 466-473.
29. Lee SW. H-cadherin, a novel cadherin with growth inhibitory functions and diminished expression in human breast cancer. Nat Med. 1996; 2: 776-782.
30. Hug C, Wang J, Ahmad NS, et al. T-cadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30/adiponectin. Proc Natl Acad Sci U S A. 2004; 101: 10308-10313.
31. Fava C, Danese E, Montagnana M, et al. A variant upstream of the CDH13 adiponectin receptor gene and metabolic syndrome in Swedes. Am J Cardiol. 2011; 108: 1432-1437.
32. Yaghootkar H, Lamina C, Scott RA, et al. Mendelian randomization studies do not support a causal role for reduced circulating adiponectin levels in insulin resistance and type 2 diabetes. Diabetes. 2013; 62: 3589-3598.
33. Kadowaki T, Yamauchi T. Adiponectin and adiponectin receptors. Endocr Rev. 2005; 26: 439-451.
34. Hara K, Boutin P, Mori Y, et al. Genetic variation in the gene encoding adiponectin is associated with an increased risk of type 2 diabetes in the Japanese population. Diabetes. 2002; 51: 536-540.
35. Menzaghi C, Trischitta V, Doria A. Genetic influences of adiponectin on insulin resistance, type 2 diabetes, and cardiovascular disease. Diabetes. 2007; 56: 1198-1209.
36. Hivert MF, Manning AK, McAteer JB, et al. Common variants in the adiponectin gene (ADIPOQ) associated with plasma adiponectin levels, type 2 diabetes, and diabetes-related quantitative traits: the Framingham Offspring Study. Diabetes. 2008; 57: 3353-3359.
37. Schwarz PE, Towers GW, Fischer S, et al. Hypoadiponectinemia is associated with progression toward type 2 diabetes and genetic variation in the ADIPOQ gene promoter. Diabetes Care. 2006; 29: 1645-1650.
38. Siitonen N, Pulkkinen L, Lindstrom J, et al. Association of ADIPOQ gene variants with body weight, type 2 diabetes and serum adiponectin concentrations: the Finnish Diabetes Prevention Study. BMC Med Genet. 2011; 12: 5.
39. Kim HS, Jo J, Lim JE, et al. Adiponectin as predictor for diabetes among pre-diabetic groups. Endocrine. 2013; 44: 411-418.
40. Kubota N, Terauchi Y, Yamauchi T, et al. Disruption of adiponectin causes insulin resistance and neointimal formation. J Biol Chem. 2002; 277: 25863-25866.
41. Hotta K, Funahashi T, Bodkin NL, et al. Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys. Diabetes. 2001; 50: 1126-1133.